newborn sequencing
Revvity, Element Biosciences to Collaborate on Newborn Sequencing Workflow
Revvity separately said that it expects Q4 2024 revenue growth of 5 percent, or 6 percent organically, year over year.
Should the results be favorable, it could lay the foundation for whole-genome sequencing to be the standard of care for newborn screening in Greece.
GeneDx Stock Soars as Firm Reports 44 Percent Revenue Growth, $1.2M Adjusted Net Income in Q3
Premium
Revenues in the third quarter were driven by diagnostic exome and genome tests, which grew 76 percent in revenue and 46 percent in volume, prompting the firm to raise its 2024 guidance.
BabySeq Project Finds Similar Rates of Genetic Risk Variants Across Diverse Groups
BabySeq2 has enrolled a more diverse cohort of participants than its predecessor, leading researchers to examine whether the rate of reportable findings differs.
The research study, run by Genomics England in collaboration with the UK's National Health Service, plans to sequence the genomes of 100,000 newborns.